Mauricio Delgado
About Mauricio Delgado
Mauricio Delgado is the Principal Cost Analyst and Business Process Lead at Boston Scientific, responsible for budgeting, forecasting, and financial process leadership for new product transfers.
Company
Mauricio Delgado currently works at Boston Scientific. In this role, he has been engaged since 2010. Boston Scientific is known for its development and manufacture of medical devices used in a broad range of interventional medical specialties, including cardiology, endoscopy, urology, and neuromodulation.
Title
Mauricio Delgado holds the position of Principal Cost Analyst / Business Process Lead at Boston Scientific. He provides critical financial analysis and process leadership.
Work Experience at Hewlett-Packard Financial Services
Mauricio Delgado worked at Hewlett-Packard Financial Services as an Accounts Payable Supervisor for BPO Americas from 2007 to 2010. In his role, he oversaw accounts payable operations and supervised business processes specific to the Americas region.
Work Experience at Hanesbrands Inc.
Prior to his role at Hewlett-Packard, Mauricio Delgado served as a Financial Consolidation Manager at Hanesbrands Inc. from 2001 to 2007. His responsibilities included managing financial consolidation processes to ensure accurate and timely financial reporting.
Education and Expertise
Mauricio Delgado studied at Universidad Rafael Belloso Chacín where he completed a Licenciatura in Administracion de Empresas from 1992 to 1997. His academic background has provided a robust foundation for his career in financial analysis and business process management.
Key Responsibilities at Boston Scientific
At Boston Scientific, Mauricio leads the financial processes for new product transfers, focusing on urethral stents and drainage catheters. He plays a pivotal role in budgeting and forecasting and is responsible for tracking and analyzing cost reduction projects to heighten financial efficiency. Additionally, he supports base business operations through result tracking and analysis for specific medical device businesses.